Mill Capital Management’s Elevance Health ELV Stock Holding History

Mill Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.86M	Sell	9,938 -105	-1%	-$41.9K	0.25%	46
2026 Q2	$3.88M	Sell	10,043 -99	-1%	-$36.7K	0.26%	45
2026 Q1	$2.97M	Hold	10,142	–	–	0.23%	48
2025 Q4	$3.56M	Hold	10,142	–	–	0.26%	46
2025 Q3	$3.28M	Hold	10,142	–	–	0.24%	46
2025 Q2	$3.94M	Hold	10,142	–	–	0.31%	42
2025 Q1	$4.41M	Sell	10,142 -91	-0.9%	-$36.5K	0.35%	40
2024 Q4	$3.77M	Sell	10,233 -175	-2%	-$73.2K	0.3%	41
2024 Q3	$5.41M	Sell	10,408 -50	-0.5%	-$26.7K	0.42%	38
2024 Q2	$5.67M	Hold	10,458	–	–	0.47%	37
2024 Q1	$5.42M	Hold	10,458	–	–	0.45%	39
2023 Q4	$4.93M	Hold	10,458	–	–	0.44%	40
2023 Q3	$4.55M	Sell	10,458 -10	-0.1%	-$4.54K	0.45%	41
2023 Q2	$4.65M	Hold	10,468	–	–	0.44%	40
2023 Q1	$4.81M	Hold	10,468	–	–	0.49%	39
2022 Q4	$5.37M	Sell	10,468 -20	-0.2%	-$10.2K	0.59%	38
2022 Q3	$4.76M	Buy	10,488 +10	+0.1%	+$4.78K	0.56%	39
2022 Q2	$5.06M	Hold	10,478	–	–	0.56%	39
2022 Q1	$5.15M	Hold	10,478	–	–	0.49%	38
2021 Q4	$4.86M	Buy	+10,478	New	+$4.41M	0.5%	40

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

ACR Alpine Capital Research St. Louis, Missouri $7.35B AUM 21.37% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Focused Investors Los Angeles, California $2.41B AUM 10.28% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Yacktman Asset Management Austin, Texas $8.38B AUM 19.52% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mill Capital Management's ELV Position: Q3 2026 in Review

Mill Capital Management reduced its Elevance Health (ELV) stake by 1% in Q3 2026, selling an estimated $41.9K and leaving 9,938 shares worth $3.86M. The position accounts for 0.25% of the portfolio, ranked #46.

Mill Capital Management first reported a position in ELV in Q4 2021 and has held it in 20 quarters since. The position peaked at $5.67M in Q2 2024. 644 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Mill Capital Management held 9,938 shares of Elevance Health worth $3.86M as of Q3 2026.
Mill Capital Management sold 105 Elevance Health shares in Q3 2026, an estimated $41.9K.
Elevance Health made up 0.25% of Mill Capital Management's portfolio in Q3 2026, its #46 holding.
Mill Capital Management first reported a position in Elevance Health in Q4 2021 and has held it in 20 quarters since.
Mill Capital Management's Elevance Health position peaked at $5.67M in Q2 2024.
644 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Mill Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.